A novel coronavirus infection was identified in December 2019, which confirmed as severe acute respiratory syndrome caused by infection with a new Betacoronavirus. The World Health Organization (WHO) named this new corona-virus as “SARS-CoV-2” and the disease as “COVID-19” that has been causing hundreds of thousands of confirmed human infections worldwide.
MDx COVID-19 Ag Rapid Test is a lateral flow immunochromatography assay for the qualitative detection and diagnosis of SARS-CoV-2 in nasopharyngeal swabs, without using viral transport media. This test can be a supplemental diagnostic assay to real-time PCR assay in advanced laboratory for rapid diagnosis of COVID-19 infection. In addition, this rapid test can be utilized in limited facility by operators with minimum training.
A colored band should always be visualized at C line regardless of the results at T line.
If C line is not visualized, it is a no test. The retest is recommended using new Test Device.
|MFDS License No.||Cat No.||Product Name||Quantity|
|20-960||MDX-CVD-22||MDx COVID-19 Ag Rapid Test||20 Tests/Box|